{"id":23795,"date":"2022-03-30T12:24:07","date_gmt":"2022-03-30T12:24:07","guid":{"rendered":"https:\/\/celonpharma.com\/?p=23795"},"modified":"2022-03-30T12:24:07","modified_gmt":"2022-03-30T12:24:07","slug":"jefferies-initiates-analytical-coverage-of-celon-pharma","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/","title":{"rendered":"Jefferies initiates analytical coverage of Celon Pharma"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Jefferies initiates analytical coverage of Celon Pharma, with the recommendation: Buy and the target price of PLN 37.50. The report is available to Jefferies customers.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Lucy Codrington, MBChB | Equity Analyst, European Healthcare<br>Jefferies International Ltd | 100 Bishopsgate | London | EC2N 4JL |<br><a href=\"mailto:lcodrington@jefferies.com\">lcodrington@jefferies.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jefferies initiates analytical coverage of Celon Pharma, with the recommendation: Buy and the target price of PLN 37.50. The report is available to Jefferies customers. Lucy Codrington, MBChB | Equity Analyst, European HealthcareJefferies International Ltd | 100 Bishopsgate | London | EC2N 4JL |lcodrington@jefferies.com<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-23795","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Jefferies initiates analytical coverage of Celon Pharma - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jefferies initiates analytical coverage of Celon Pharma - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"Jefferies initiates analytical coverage of Celon Pharma, with the recommendation: Buy and the target price of PLN 37.50. The report is available to Jefferies customers. Lucy Codrington, MBChB | Equity Analyst, European HealthcareJefferies International Ltd | 100 Bishopsgate | London | EC2N 4JL |lcodrington@jefferies.com\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-30T12:24:07+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/\",\"url\":\"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/\",\"name\":\"Jefferies initiates analytical coverage of Celon Pharma - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"datePublished\":\"2022-03-30T12:24:07+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jefferies initiates analytical coverage of Celon Pharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jefferies initiates analytical coverage of Celon Pharma - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/","og_locale":"en_US","og_type":"article","og_title":"Jefferies initiates analytical coverage of Celon Pharma - CelonGROUP","og_description":"Jefferies initiates analytical coverage of Celon Pharma, with the recommendation: Buy and the target price of PLN 37.50. The report is available to Jefferies customers. Lucy Codrington, MBChB | Equity Analyst, European HealthcareJefferies International Ltd | 100 Bishopsgate | London | EC2N 4JL |lcodrington@jefferies.com","og_url":"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/","og_site_name":"CelonGROUP","article_published_time":"2022-03-30T12:24:07+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/","url":"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/","name":"Jefferies initiates analytical coverage of Celon Pharma - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"datePublished":"2022-03-30T12:24:07+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celon.group\/en\/2022\/03\/30\/jefferies-initiates-analytical-coverage-of-celon-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"Jefferies initiates analytical coverage of Celon Pharma"}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/23795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=23795"}],"version-history":[{"count":0,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/23795\/revisions"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=23795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=23795"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=23795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}